Equities analysts forecast that Stepan (NYSE:SCL) will post $518.85 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Stepan’s earnings, with estimates ranging from $514.80 million to $522.90 million. Stepan reported sales of $519.87 million in the same quarter last year, which indicates a negative year-over-year growth rate of 0.2%. The firm is expected to issue its next quarterly earnings report before the market opens on Wednesday, July 24th.

According to Zacks, analysts expect that Stepan will report full year sales of $2.02 billion for the current year, with estimates ranging from $2.02 billion to $2.03 billion. For the next fiscal year, analysts expect that the company will post sales of $2.14 billion, with estimates ranging from $2.09 billion to $2.23 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Stepan.

Stepan (NYSE:SCL) last posted its quarterly earnings data on Tuesday, April 30th. The basic materials company reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.04. Stepan had a net margin of 5.40% and a return on equity of 14.24%. The company had revenue of $489.17 million during the quarter, compared to the consensus estimate of $510.57 million. During the same period in the prior year, the business posted $1.44 EPS. The company’s quarterly revenue was down 2.0% on a year-over-year basis.

A number of research firms have recently commented on SCL. ValuEngine downgraded shares of Whiting USA Trust II from a “hold” rating to a “sell” rating in a research note on Tuesday, May 7th. Zacks Investment Research upgraded shares of HB Fuller from a “sell” rating to a “hold” rating in a research note on Wednesday, July 3rd. Finally, Royal Bank of Canada set a $184.00 price objective on shares of Jazz Pharmaceuticals and gave the stock a “buy” rating in a research note on Wednesday, July 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. Stepan currently has a consensus rating of “Hold” and an average price target of $67.80.

In other news, Director Gregory E. Lawton sold 2,201 shares of the company’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $91.14, for a total value of $200,599.14. Following the sale, the director now directly owns 17,315 shares of the company’s stock, valued at approximately $1,578,089.10. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Luis Rojo bought 300 shares of the company’s stock in a transaction dated Wednesday, May 22nd. The stock was purchased at an average cost of $86.64 per share, for a total transaction of $25,992.00. Following the completion of the acquisition, the chief financial officer now owns 1,900 shares in the company, valued at approximately $164,616. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 1,000 shares of company stock worth $87,880 and sold 5,332 shares worth $486,759. 11.40% of the stock is currently owned by corporate insiders.

Several hedge funds have recently modified their holdings of SCL. Nisa Investment Advisors LLC boosted its position in shares of Stepan by 9.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 11,525 shares of the basic materials company’s stock worth $1,059,000 after acquiring an additional 1,000 shares in the last quarter. Hennessy Advisors Inc. acquired a new stake in Stepan in the second quarter valued at approximately $2,987,000. Contravisory Investment Management Inc. acquired a new stake in Stepan in the second quarter valued at approximately $151,000. WINTON GROUP Ltd boosted its position in Stepan by 9.7% in the second quarter. WINTON GROUP Ltd now owns 9,543 shares of the basic materials company’s stock valued at $877,000 after buying an additional 844 shares in the last quarter. Finally, FMR LLC boosted its position in Stepan by 189.0% in the first quarter. FMR LLC now owns 341 shares of the basic materials company’s stock valued at $30,000 after buying an additional 223 shares in the last quarter. 71.71% of the stock is currently owned by institutional investors.

Shares of Stepan stock traded up $1.92 during trading hours on Friday, reaching $92.71. 54,833 shares of the company’s stock were exchanged, compared to its average volume of 77,046. The business’s 50 day moving average is $89.67. Stepan has a fifty-two week low of $69.17 and a fifty-two week high of $95.32. The company has a current ratio of 2.74, a quick ratio of 2.01 and a debt-to-equity ratio of 0.32. The firm has a market cap of $2.05 billion, a PE ratio of 19.00 and a beta of 1.29.

The company also recently announced a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Friday, May 31st were issued a $0.25 dividend. The ex-dividend date was Thursday, May 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.08%. Stepan’s payout ratio is 20.49%.

Stepan Company Profile

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products.

Recommended Story: Do Tariffs Work?

Get a free copy of the Zacks research report on Stepan (SCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.